Position in AMGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$347,997
-$1,038 QoQ
Shares Held
961
-3.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#2,447
of 3,140 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BlackDiamond Wealth Management, LLC holds $5,374,147 across 7 Drug Manufacturers - General names. AMGN ranks #5 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,209 | $1,450,110 | |
| 2 | ABBV |
AbbVie Inc.
|
5,233 | $1,316,832 | |
| 3 | JNJ |
Johnson & Johnson
|
4,945 | $1,255,881 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,785 | $486,372 | |
| 5 | AMGN |
Amgen Inc
This page
|
961 | $347,997 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,335 | $295,003 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,852 | $221,952 |
All Filings in AMGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $347,997 | 961 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $349,035 | 992 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $306,362 | 936 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $274,862 | 974 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $249,892 | 895 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $256,717 | 824 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $207,208 | 795 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $286,444 | 889 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $205,279 | 657 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||